| Target Species |
Dogs |
| Active Substances |
Milbemycin Oxime (A3 and A4), Praziquantel |
| Pharmaceutical Form |
Chewable tablet |
| Therapeutic Group |
Anthelmintic |
| Authorisation Route |
National |
| Legal Category |
POM-V |
| Controlled Drug Status |
Not a controlled drug |
| Marketing Authorisation Holder |
Krka d.d., Novo Mesto |
| Distributors |
<span>Krka d.d., Novo Mesto</span> |
| Territory |
Great Britain |
| SPC |
Aderexa 12.5 mg/125 mg Chewable Tablets for Dogs Weighing at Least 5 kg SPC |
| UKPAR |
Aderexa 12.5 mg/125 mg Chewable Tablets for Dogs Weighing at Least 5 kg UKPAR |
